RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
Clinical trial NCT00081874 · COMPLETED
Trial details
- NCT number
- NCT00081874
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2006-09-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.